With one exception—the ACS’s laudable and successful multi-decade crusade against smoking—the research and advocacy ACS funds is all about “preventive screening” (since when is a diagnosis of a late-stage existing condition considered prevention?) and molecular mechanisms of cancer development that might lend themselves to the latest toxic drug or genetic manipulation.
